Bausch Health Americas, Inc.
Clinical trials sponsored by Bausch Health Americas, Inc., explained in plain language.
A subsidiary of Bausch Health, focused on pharmaceuticals and medical devices in the Americas.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for kids with colitis: budesonide pill trial aims for remission Results expected Dec 2026 (estimated)
- New radiofrequency treatment aims to tighten sagging skin without surgery Results expected Feb 2027 (estimated)
- New hope for Kids' diarrhea: drug plus fluids tested Results expected Apr 2027 (estimated)
-
New pill could ease ulcerative colitis symptoms
Disease control CompletedThis study tested an oral drug called amiselimod (MT-1303) in 322 adults with mild to moderate ulcerative colitis. Participants received either a low dose, high dose, or placebo for 12 weeks, with an optional 36-week open-label period. The goal was to see if the drug could reduce…
Phase 2 • Sponsor: Bausch Health Americas, Inc. • Aim: Disease control
Last updated Jun 26, 2026 15:08 UTC
-
New acne gel put to the test in everyday life
Symptom relief CompletedThis study follows about 200 people aged 12 and older in Canada who are using a prescription gel containing clindamycin, adapalene, and benzoyl peroxide for acne. Researchers want to see how satisfied patients are, how well they stick to the treatment, and how it affects their qu…
Sponsor: Bausch Health Americas, Inc. • Aim: Symptom relief
Last updated Sep 10, 2026 02:00 UTC
-
New lotion for Kids' psoriasis under the microscope
Symptom relief CompletedThis study looked at how a prescription lotion (IDP-118) works in children aged 4 to 16 with moderate to severe plaque psoriasis. Researchers measured how much of the drug enters the bloodstream and whether it affects the body's stress hormone system (HPA axis). The goal was to c…
Phase 4 • Sponsor: Bausch Health Americas, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Could a pill ease tummy troubles for kids with IBS-C?
Symptom relief CompletedThis study tested whether plecanatide (Trulance), a drug already approved for adults, can help children aged 6 to 17 with irritable bowel syndrome with constipation (IBS-C). Over 4 weeks, 218 participants took either plecanatide or a placebo daily and tracked their bowel movement…
Phase 2 • Sponsor: Bausch Health Americas, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
New acne gel shows promise in Head-to-Head trial
Symptom relief CompletedThis Phase 2 trial tested a new acne gel called IDP-126 against a standard gel (Epiduo Forte) and a placebo gel in 686 people aged 12 and older with moderate to severe acne. Participants applied the gel once daily for 12 weeks. Researchers measured changes in acne lesion counts a…
Phase 2 • Sponsor: Bausch Health Americas, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC